tech_banner
Matreya/N-Tricosanoyl ceramide trihexoside/1524/500 µg
  • Catalog #:1524
  • Scientific Name:N-Tricosanoyl ceramide trihexoside
  • Common Name:N-C23:0-Ceramide trihexoside; N-Tricosanoyl globotriaosylceramide
  • Empirical Formula:C59H111NO18
  • SDSView Safety Data Sheet
  • Data Sheet:View Data Sheet
  • Formula Weight:1122
  • Unit:500 µg
  • Solvent:none
  • Source:semisynthetic
  • Purity:98+%
  • Analytical Methods:TLC, identity confirmed by MS
  • Natural Source:porcine RBC
  • Solubility:DMSO, hot methanol, chloroform/methanol, 2:1
  • Physical Appearance:solid
  • Storage:-20°C
  • Dry Ice:No
  • Hazardous:No
  • Literature References:1. S. Ashkenazi, and T. Cleary, \"Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their naturalreceptor.” J Clin Microbiol., Vol. 27:6 pp. 1145-1150, 19892. S. Bekri, et al. \"The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: areview of the literature\" Cardiovasc Hematol Agents Med Chem, Vol. 4:4 pp. 289–297, 20063. J. Groener, et al. \"HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma” ClinChem., Vol. 53:4 pp. 742-747, 20074. K. Mills, A. Johnson, B. Winchester, \"Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabrydisease by tandem mass spectrometry” FEBS Lett., Vol. 27 pp. 171-176, 20025. C. Menge, et al. \"Globotriaosylceramide (Gb(3)/CD77) is synthesized and surface expressed by bovine lymphocytes upon activation in vitro” VetImmunol Immunopathol., Vol. 83 pp.19-36, 2001